Iranian Journal of Public Health 2018. 47(8):1220-1221.

The High Prevalence of Osteoporosis as a Preventable Disease: The Need for Greater Attention to Prevention Programs in Iran



Full Text:



Cosman F, de Beur SJ, LeBoff MS et al (2014). Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int, 25:2359-81.

Doosti Irani A, Poorolajal J, Khalilian A et al (2013). Prevalence of osteoporosis in Iran: A meta-analysis. J Res Med Sci, 18:759-66.

El-Hajj Fuleihan G, Adib G, Nauroy L (2011). The middle east & Africa regional audit, epidemiology, costs & burden of osteoporosis in 2011. International Osteoporosis Foundation, Switzerland pp. 102011-105000.

WHO Iran (Islamic Republic of): WHO statistical profile.

Institute for Health Metrics and Evaluation Iran: How long do people live?

IRNA Iran’s per capita milk consumption.

Hashemipour S, Larijani B, Adibi H et al (2004). Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health, 4:38.

Hovsepian S, Amini M, Aminorroaya A et al (2011). Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran. J Health Popul Nutr, 29:149-55.

Moussavi M, Heidarpour R, Aminorroaya A et al (2005). Prevalence of vitamin D deficiency in Isfahani high school students in 2004. Horm Res, 64:144-8.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.